Effects of estradiol alone and combined with norethisterone acetate on pulse-wave velocity in hypertensive postmenopausal women

References

• Mansur A P, Aldrighi J A, Ramires J AF. Trends in death from circulatory diseases in Brazil between 1979 and 1996. Arq Bras Cardiol 2001; 76: 504–510
   Google Scholar
• Aldrighi J M, Martinez T LR, Silva F CP. Cardiovascular disease and hormone replacement therapy. Arq Bras Cardiol 1995; 65: 249–254
   PubMedGoogle Scholar
• Kalin M F, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids 1990; 55: 330–352
   PubMed Web of Science ®Google Scholar
• Staessen J A, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens 1998; 12: 587–592
   PubMed Web of Science ®Google Scholar
• Sauerbronn A VD, Fonseca A M, Bagnoli V R, Saldiva P H. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 2000; 68: 35–41
   PubMed Web of Science ®Google Scholar
• Bourne T, Hillard T C, Whitehead M I, Crook D, Campbell S. Oestrogens arterial status and postmenopausal women. Lancet 1990; 355: 1470–1471
   Google Scholar
• Herrington D, Braden G A, Williams J K, Morgan T M. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol 1994; 73: 951–952
   PubMed Web of Science ®Google Scholar
• Stampfer M J, Colditz G A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47–63
   PubMed Web of Science ®Google Scholar
• Gilligan D M, Badar D M, Panza J A, Quyyumi A A, Cannon R O. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90: 786–791
   PubMed Web of Science ®Google Scholar
• Alecrin I N, Aldrighi J M, Caldas M A, Gebara O CE, Lopes N HM, Ramires J AF. Acute and chronic effects of estradiol on left ventricular diastolic function in hypertensive postmenopausal women with left ventricular diastolic dysfunction. Heart 2004; 90: 777–781
   PubMed Web of Science ®Google Scholar
• Riedel M, Oeltermann A, Mugge A, Creutzig A, Rafflenbeul W, Lichetlen P. Vascular responses to 17β-oestradiol in postmenopausal women. Eur J Clin Invest 1995; 25: 44–47
   PubMedGoogle Scholar
• McDonald D A. Blood flow in arteries: Theoretical, experimental and clinical principles. 4th ed. Arnold, London 1998; 77–142, 216–269, 283–359, 398–437
   Google Scholar
• Bortolotto L A, Blacher J, Kondo T, Takazawa K, Safar M E. Assessment of vascular aging and atherosclerosis in hypertensive subjects: second derivate of photoplethysmogram versus pulse wave velocity. Am J Hypertens 2000; 13: 165–171
   PubMed Web of Science ®Google Scholar
• Rajkumar C, Kingwell B A, Cameron J D, Waddell T, Mehra R, Christophidis N, Komesaroff P A, McGrath B, Jennings G L, Sudhir K, et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol 1997; 30: 350–356
   PubMed Web of Science ®Google Scholar
• Stefanadis C, Tsiamis E, Dernellis J, Toutouzas P. Effect of estrogen on aortic function in postmenopausal women. Am J Physiol 1999; 276(2 Pt 2)H658–H662
   Google Scholar
• Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157: 2413–2446
   PubMed Web of Science ®Google Scholar
• Blacher J, Guerin A, Pannier B, Marchais S, Safar M, London G. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434–2439
   PubMed Web of Science ®Google Scholar
• Blacher J, Asmar R, Djane S, London G, Safar M. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 3: 1111–1117
   Google Scholar
• Bortolotto L A, Safar M E, Billaud E, Lacroix C, Asmar R, London G M, Blacher J. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension 1999; 34: 837–842
   PubMed Web of Science ®Google Scholar
• Lehmann E D, Riley W A, Clarkson P, Gosling R G. Non invasive assessment of cardiovascular disease in diabetes mellitus. Lancet 1997; 350(Suppl 1)14–19
   Google Scholar
• Asmar R, Topouchian J, Pannier B, Benetos A, Safar M. Pulse wave velocity as endpoint in large-scale intervention trial. The Complior Study. J Hypertens 2001; 19: 813–818
   PubMed Web of Science ®Google Scholar
• Bank A J, Kaiser D R. Smooth muscle relaxation: effects on arterial compliance, distensibility, elastic modulus, and pulse wave velocity. Hypertension 1998; 32: 356–359
   PubMed Web of Science ®Google Scholar
• Cohn J N. Vascular wall function as a risk marker for cardiovascular disease. J Hypertens 1999; 17(Suppl 5)S41–S44
   Google Scholar
• Asmar R, Benetos A, Topouchian J, Laurent S, Pannier B. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485–490
   PubMed Web of Science ®Google Scholar
• Teede H J, Lorang Y L, Kotsopoulos D. A placebo-controlled trial of long-term combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Clin Endocrinol (Oxf) 2001; 55: 673–682
   PubMed Web of Science ®Google Scholar
• Tanaka H, De Souza C A, Seals D R. Arterial stiffness and hormonal replacement use in healthy postmenopausal women. J Gerontol 1998; 53: M344–M346
   Google Scholar
• Waddell T K, Rajkumar C, Cameron J D, Jennings G L, Dart A M, Kingwell B A. Withdrawal of hormonal therapy for 4 weeks decreases arterial compliance in postmenopausal women. J Hypertens 1999; 17: 413–418
   PubMed Web of Science ®Google Scholar
• Blacher J, Raison J, Safar M G. Increase arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after agude administration of the ace inhibitor moexipril. Cardiovasc Drugs Ther 1998; 12: 409–414
   PubMed Web of Science ®Google Scholar
• Sumino H, Ichikawa S, Kasama S, Takahashi T, Kumakura H, Takayama Y, Kanda T, Kurabayashi M. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women. Atherosclerosis, 2006 Feb 7; [Epub ahead of print]
   Google Scholar
• Cameron J D. Estimation of arterial mechanics in clinical practice and as a research technique. Clin Exp Pharmacol Physiol 1999; 26: 285–294
   PubMed Web of Science ®Google Scholar
• PEPI Trial. Effects of estrogen or estrogen/progestin regiments on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. J Am Med Assoc 1995; 273: 199–208
   PubMed Web of Science ®Google Scholar
• Pfeffer R, Kurosaki T T, Charlton S. Estrogen use and blood pressure in later life. Am J Epidemiol 1979; 110: 469–478
   PubMedGoogle Scholar
• Vilodre L C, Osorio Wender M C, Sisson de Castro J A, Reis F M, Ruscher S, Magalhães J A, Spritzer P M. Endometrial response to a cyclic regimen of percutaneous 17 g estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension. Gynecol Endocrinol 2003; 17: 323–328
   PubMed Web of Science ®Google Scholar
• Avolio A P, Deng F Q, Li W Q, Luo Y F, Huang Z D, Xing L F, O'Rourke M F. Effects of aging on arterial distensibiity in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985; 71: 202–210
   PubMed Web of Science ®Google Scholar
• Banka C L. Non-genomic actions of estrogens as antioxidants. Estrogen and vessel wall, G M Rubanyi, R Kauffman. Harwood Academic Publishers, Australia 1998; 91–106
   Google Scholar
• Alper T, Cetinkaya M B, Kokcu A, Yanik F F, Malatyalioglu E. Do lipid profiles of postmenopausal women under oral hormone replacement therapy remain stable or reveal a multiphasic course in time?. Gynecol Endocrinol 2004; 18: 199–205
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R. Progestins and the cardiovascular system. Hormone replacement therapy and cardiovascular disease, A R Genazzani. Parthenon, New York 2001; 93–100
   Google Scholar
• Girerd X, Chanudet X, Larrogue P, Safar M E. Early arterial modifications in young patients with borderline hypertension. J Hypertens 1989; 7(Suppl 1)456–457
   Google Scholar
• Rosano G M, Mercuro G, Vitale C, Rosini P, Galetta P, Fini M. How progestins influence the cardiovascular effect of hormone replacement therapy. Gynecol Endocrinol 2001; 15(Suppl 6)9–17
   PubMedGoogle Scholar
• Oliveira R L, Aldrighi J M, Gebara O E, Rocha T R, D'Amico E, Rosano G M, Ramires J A. Postmenopausal hormone replacement therapy increases plasmatic thromboxane β2. Int J Cardiol 2005; 99: 449–454
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Sundaram K. Pharmacology of new progestogens: the 19-nonprogesterone derivatives. Progestins and antiprogestins in clinical practice, R Sitruk-Ware, D R Mishell, Jr. Marcel Dekker Inc., New York 2000; 156–161
   Google Scholar
• Miura S, Tanaka E, Mori A, Toya M, Takahashi K, Nakahara K, Ohmichi M, Kurachi H. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women. Maturitas 2003; 45: 293–298
   PubMed Web of Science ®Google Scholar